Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
An Open Label, Pilot Study Evaluating the Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
In the register
The register attaches this trial to Minoxidil (low-dose oral), currently at “Marketed, off-label” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Early phase 1
- Sponsor
- Northwestern University
- Participants (registry)
- 14
- Start
- April 2019
- Primary completion
- January 2024
- Study completion
- August 2026
- Last registry update
- April 2026
- Countries
- United States
Conditions studied: Permanent Chemotherapy-induced Alopecia
Interventions: oral minoxidil
Other trials of Minoxidil (low-dose oral)
- NCT07018349Not yet recruiting
Low Dose Oral Minoxdil in Androgenic Alopecia
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.